Statement of Principles concerning cholelithiasis (Balance of Probabilities) (No. 52 of 2016) (Cth)

Case

Statement of Principles

concerning

CHOLELITHIASIS
(Balance of Probabilities)

(No. 52 of 2016)

The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans’ Entitlements Act 1986.

Dated    22 April 2016

The Common Seal of the
Repatriation Medical Authority
was affixed to this instrument
at the direction of:

Professor Nicholas Saunders AO
Chairperson

Contents

1Name........................................................................................................................................... 3

2Commencement........................................................................................................................ 3

3Authority..................................................................................................................................... 3

4Revocation................................................................................................................................. 3

5Application................................................................................................................................. 3

6Definitions.................................................................................................................................. 3

7Kind of injury, disease or death to which this Statement of Principles relates............... 3

8Basis for determining the factors........................................................................................... 4

9Factors that must exist............................................................................................................. 4

10Relationship to service............................................................................................................. 7

11Factors referring to an injury or disease covered by another Statement of Principles. 8

Schedule 1 - Dictionary............................................................................................. 9

1Definitions.................................................................................................................................. 9

  1. Name

    This is the Statement of Principles concerning cholelithiasis (Balance of Probabilities) (No. 52 of 2016).

  2. Commencement

    This instrument commences on 23 May 2016.

  3. Authority

    This instrument is made under subsection 196B(3) of the Veterans’ Entitlements Act 1986.

  4. Revocation

    The Statement of Principles concerning cholelithiasis No. 8 of 2008 made under subsection 196B(3) of the VEA is revoked.

  5. Application

    This instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.

  6. Definitions

    The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.

  7. Kind of injury, disease or death to which this Statement of Principles relates

    (1)This Statement of Principles is about cholelithiasis and death from cholelithiasis.

    Meaning of cholelithiasis

    (2)For the purposes of this Statement of Principles, cholelithiasis means the aggregation of bile constituents into a stone or calculus with a diameter exceeding two millimetres, in the gallbladder or in the intrahepatic or extrahepatic bile ducts; and which may present as biliary colic.

    (3)While cholelithiasis attracts ICD‑10‑AM code K80, in applying this Statement of Principles the meaning of cholelithiasis is that given in subsection (2).

    (4)For subsection (3), a reference to an ICD‑10‑AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD‑10‑AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978‑1‑76007‑020‑5.

    Death from cholelithiasis

    (5)For the purposes of this Statement of Principles, cholelithiasis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person’s cholelithiasis.

    Note: terminal event is defined in the Schedule 1 – Dictionary.

  8. Basis for determining the factors

    On the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that cholelithiasis and death from cholelithiasis can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.

    Note: relevant service is defined in the Schedule 1 – Dictionary.

  9. Factors that must exist

    At least one of the following factors must exist before it can be said that, on the balance of probabilities, cholelithiasis or death from cholelithiasis is connected with the circumstances of a person’s relevant service:

    (1)being obese for at least the five years before the clinical onset of cholelithiasis;

    Note: being obese is defined in the Schedule 1 - Dictionary.

    (2)having rapid and extreme weight loss within the one year before the clinical onset of cholelithiasis;

    Note: rapid and extreme weight loss is defined in the Schedule 1 - Dictionary.

    (3)having a very low calorie diet for the one year before the clinical onset of cholelithiasis;

    Note: very low calorie diet is defined in the Schedule 1 - Dictionary.

    (4)undergoing bariatric surgery within the two years before the clinical onset of cholelithiasis;

    Note: bariatric surgery is defined in the Schedule 1 - Dictionary.

    (5)taking a drug or a drug from a class of drugs from the specified list of drugs, for a continuous period of at least six months before the clinical onset of cholelithiasis, and where treatment has ceased, the clinical onset of cholelithiasis has occurred within three months of cessation;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

    (6)having cirrhosis of the liver at the time of the clinical onset of cholelithiasis;

    (7)having a haemolytic disease at the time of the clinical onset of cholelithiasis;

    Note: haemolytic disease is defined in the Schedule 1 - Dictionary.

    (8)having Crohn's disease at the time of the clinical onset of cholelithiasis;

    Note: Crohn's disease is defined in the Schedule 1 - Dictionary.

    (9)having an ileal resection or ileal bypass before the clinical onset of cholelithiasis;

    (10)having type 2 diabetes mellitus at the time of the clinical onset of cholelithiasis;

    Note: type 2 diabetes mellitus is defined in the Schedule 1 - Dictionary.

    (11)having total parenteral nutrition for a continuous period of at least three weeks before the clinical onset of cholelithiasis, and where total parenteral nutrition has ceased, the clinical onset of cholelithiasis has occurred within 30 days of cessation;

    Note: total parenteral nutrition is defined in the Schedule 1 - Dictionary.

    (12)being pregnant within the three months before the clinical onset of cholelithiasis;

    (13)having estrogen therapy for a continuous period of at least six months before the clinical onset of cholelithiasis, and where estrogen therapy has ceased, the clinical onset of cholelithiasis has occurred within three months of cessation;

    Note: estrogen therapy is defined in the Schedule 1 - Dictionary.

    (14)having a spinal cord injury at the time of the clinical onset of cholelithiasis;

    Note: spinal cord injury is defined in the Schedule 1 - Dictionary.

    (15)having a gastric or oesophageal resection, or another operation that included a vagotomy, before the clinical onset of cholelithiasis;

    (16)having a foreign body in the biliary tract, or a mechanical obstruction of the biliary tract, before the clinical onset of cholelithiasis;

    Note: foreign body and mechanical obstruction of the biliary tract are defined in the Schedule 1 - Dictionary.

    (17)having a parasitic disease from the specified list of parasitic diseases of the biliary tract, at the time of the clinical onset of cholelithiasis;

    Note: specified list of parasitic diseases is defined in the Schedule 1 - Dictionary.

    (18)having cholangiohepatitis or recurrent pyogenic cholangitis at the time of the clinical onset of cholelithiasis;

    (19)having a somatostatinoma at the time of the clinical onset of cholelithiasis;

    Note: somatostatinoma is defined in the Schedule 1 - Dictionary.

    (20)an inability to undertake any physical activity greater than three METs for at least the five years before the clinical onset of cholelithiasis;

    Note: MET is defined in the Schedule 1 - Dictionary.

    (21)being obese for at least the five years before the clinical worsening of cholelithiasis;

    Note: being obese is defined in the Schedule 1 - Dictionary.

    (22)having rapid and extreme weight loss within the one year before the clinical worsening of cholelithiasis;

    Note: rapid and extreme weight loss is defined in the Schedule 1 - Dictionary.

    (23)having a very low calorie diet for a continuous period of the one year before the clinical worsening of cholelithiasis;

    Note: very low calorie diet is defined in the Schedule 1 - Dictionary.

    (24)undergoing bariatric surgery within the two years before the clinical worsening of cholelithiasis;

    Note: bariatric surgery is defined in the Schedule 1 - Dictionary.

    (25)taking a drug or a drug from a class of drugs from the specified list of drugs, for a continuous period of at least six months before the clinical worsening of cholelithiasis, and where treatment has ceased, the clinical worsening of cholelithiasis has occurred within three months of cessation;

    Note: specified list of drugs is defined in the Schedule 1 - Dictionary.

    (26)having cirrhosis of the liver at the time of the clinical worsening of cholelithiasis;

    (27)having a haemolytic disease at the time of the clinical worsening of cholelithiasis;

    Note: haemolytic disease is defined in the Schedule 1 - Dictionary.

    (28)having Crohn's disease at the time of the clinical worsening of cholelithiasis;

    Note: Crohn's disease is defined in the Schedule 1 - Dictionary.

    (29)having an ileal resection or ileal bypass before the clinical worsening of cholelithiasis;

    (30)having type 2 diabetes mellitus at the time of the clinical worsening of cholelithiasis;

    Note: type 2 diabetes mellitus is defined in the Schedule 1 - Dictionary.

    (31)having total parenteral nutrition for a continuous period of at least three weeks before the clinical worsening of cholelithiasis, and where total parenteral nutrition has ceased, the clinical worsening of cholelithiasis has occurred within 30 days of cessation;

    Note: total parenteral nutrition is defined in the Schedule 1 - Dictionary.

    (32)being pregnant within the three months before the clinical worsening of cholelithiasis;

    (33)having estrogen therapy for a continuous period of at least six months before the clinical worsening of cholelithiasis, and where estrogen therapy has ceased, the clinical worsening of cholelithiasis has occurred within three months of cessation;

    Note: estrogen therapy is defined in the Schedule 1 - Dictionary.

    (34)having a spinal cord injury at the time of the clinical worsening of cholelithiasis;

    Note: spinal cord injury is defined in the Schedule 1 - Dictionary.

    (35)having a gastric or oesophageal resection, or another operation that included a vagotomy, before the clinical worsening of cholelithiasis;

    (36)having a foreign body in the biliary tract, or a mechanical obstruction of the biliary tract, before the clinical worsening of cholelithiasis;

    Note: foreign body and mechanical obstruction of the biliary tract are defined in the Schedule 1 - Dictionary.

    (37)having a parasitic disease from the specified list of parasitic diseases of the biliary tract, at the time of the clinical worsening of cholelithiasis;

    Note: specified list of parasitic diseases is defined in the Schedule 1 - Dictionary.

    (38)having cholangiohepatitis or recurrent pyogenic cholangitis at the time of the clinical worsening of cholelithiasis;

    (39)having a somatostatinoma at the time of the clinical worsening of cholelithiasis;

    Note: somatostatinoma is defined in the Schedule 1 - Dictionary.

    (40)an inability to undertake any physical activity greater than three METs for at least the five years before the clinical worsening of cholelithiasis;

    Note: MET is defined in the Schedule 1 - Dictionary.

    (41)inability to obtain appropriate clinical management for cholelithiasis.

  10. Relationship to service

    (1)The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.

    (2)The factors set out in subsections 9(21) to 9(41) apply only to material contribution to, or aggravation of, cholelithiasis where the person’s cholelithiasis was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

  11. Factors referring to an injury or disease covered by another Statement of Principles

    In this Statement of Principles:

    (1)if a factor referred to in section 9 applies in relation to a person; and

    (2)that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;

    then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.

Schedule 1 - Dictionary

Note: See Section 6

  1. Definitions

    In this instrument:

    bariatric surgery means weight reduction surgical procedures including gastrojejunostomy, gastric stapling, vertical banded gastroplasty and gastrectomy with Roux-en-Y anastomosis.

    being obese means:

    (a)having a Body Mass Index (BMI) of 30 or greater; or

    (b)for males, having a waist circumference exceeding 102 centimetres; or

    (c)for females, having a waist circumference exceeding 88 centimetres.

    BMI means W/H2 and where:

    W is the person's weight in kilograms; and

    H is the person's height in metres.

    cholelithiasis—see subsection 7(2).

    Crohn's disease means a type of inflammatory bowel disease that can affect any part of the gastrointestinal tract from the mouth to the anus, particularly the small bowel, with patchy areas of transmural inflammation, and usually with prominent extrainestinal manifestations.

    estrogen therapy means the continuous, cyclical or intermittent administration of estrogen contained in medications, including the oral contraceptive pill and post-menopausal hormone replacement therapy.

    foreign body means the presence of exogenous material, including a surgical clip or stent or nonabsorbable suture, a missile fragment or shrapnel, or a fish bone.

    haemolytic disease means an acquired or inherited disorder characterised by red cell defects and breakdown with bilirubin overproduction, including thalassaemia, hereditary spherocytosis, sickle cell anaemia or haemolytic uraemic syndrome.

    mechanical obstruction of the biliary tract means a structural or disease process, including benign or malignant stricture, sclerosing cholangitis, or choledochal cyst, which narrows the lumen of the biliary tract.

    MET means a unit of measurement of the level of physical exertion.  1 MET = 3.5 ml of oxygen/kg of body weight per minute, 1.0 kcal/kg of body weight per hour or resting metabolic rate.

    MRCAmeans the Military Rehabilitation and Compensation Act 2004.

    rapid and extreme weight loss means total weight loss of at least 15% of initial body weight:

    (a)within a continuous six month period; or

    (b)at an average rate of at least 1.5 kilograms per week.

    relevant service means:

    (a)eligible war service (other than operational service) under the VEA;

    (b)defence service (other than hazardous service and British nuclear test defence service) under the VEA; or

    (c)peacetime service under the MRCA.

    somatostatinoma means a neuroendocrine neoplasm characterised by excessive secretion of somatostatin hormone by tumour cells of D-cell origin.

    specified list of drugs means:

    (a)atazanavir;

    (b)cyclosporine A;

    (c)fibrates;

    (d)somatostatin analogues;

    (e)tacrolimus; or

    (f)tamoxifen.

    specified list of parasitic diseases means:

    (a)ascariasis;

    (b)clonorchiasis;

    (c)dicrocoeliasis;

    (d)fascioliasis; or

    (e)opisthorchiasis.

    spinal cord injury means an injury to the long tracts of the spinal cord resulting in permanent motor or sensory deficits below the level of the lesion.

    terminal event means the proximate or ultimate cause of death and includes the following:

    (a) pneumonia;

    (b) respiratory failure;

    (c) cardiac arrest;

    (d) circulatory failure; or

    (e) cessation of brain function.

    total parenteral nutrition means continuous intravenous drip feeding with no feeding via mouth or gut.

    type 2 diabetes mellitus means a form of diabetes mellitus caused by variable degrees of insulin resistance and impaired insulin secretion.

    VEA means the Veterans' Entitlements Act 1986.

    very low calorie diet means having an energy intake of less than 800 kilocalories per day.

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0